Abstract

Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune neurological disorder. Osteopontin (OPN) is a secreted multifunctional phosphorylated glycoprotein that regulates various autoimmune and inflammatory diseases, but its diagnostic and prognostic values in anti-NMDAR encephalitis patients remain elusive. This retrospective study aimed to determine the levels of OPN and related cytokines in cerebrospinal fluid (CSF) of anti-NMDAR encephalitis patients and to assess their influence on disease severity so as to evaluate their efficacy as biomarkers for diagnosis and prognosis. CSF samples from 33 anti-NMDAR encephalitis, 13 viral encephalitis, and 21 controls were collected. All CSF were tested for levels of OPN and inflammation-associated cytokines [interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α] via ELISA. In addition, 15 anti-NMDAR encephalitis patients without follow-up relapse were re-examined for these four parameters 3 months later. The clinical status was evaluated by modified Rankin Scale (mRS) scores. Results showed that the CSF levels of these cytokines were increased in anti-NMDAR encephalitis patients compared to controls but not viral encephalitis patients. Their levels were decreased in remission compared with that in acute stage. Moreover, CSF OPN positively correlated with IL-6, white blood cell (WBC) counts, and C-reactive protein (CRP) levels in anti-NMDAR encephalitis patients. However, no associations were found between OPN or related cytokines and mRS scores in acute stage in anti-NMDAR encephalitis patients. Overall, CSF OPN and related cytokines were increased when anti-NMDAR encephalitis patients are in acute stage and decreased in remission, suggesting the underlying neuro-inflammatory process in this disease. However, they are not qualified with diagnostic or prognostic value.

Highlights

  • Anti-N-methyl-D-aspartate-receptor encephalitis is newly accepted as an autoimmune neurological disorder mainly affecting young women [1, 2]

  • We detected a significant increase in cerebrospinal fluid (CSF) OPN, IL-6, tumor necrosis factor (TNF)-α, and IL-10 in anti-NMDAR encephalitis patients in acute stage compared to controls, and both the levels of CSF OPN and its relevant cytokines decrease as the disease develops into the remission stage

  • We revealed that the CSF levels of OPN, IL-6, IL-10, and TNF-α were obviously higher in antiNMDAR encephalitis patients in acute stage compare to those in remission

Read more

Summary

Introduction

Anti-N-methyl-D-aspartate (anti-NMDA)-receptor encephalitis is newly accepted as an autoimmune neurological disorder mainly affecting young women [1, 2]. Typical clinical manifestation of this disease predominantly involves the progressive development of neurological and psychiatric symptoms, such as movement disorder, seizures, speech disorder, consciousness disturbances, autonomic instability, and central hypoventilation [3]. The production of antibodies to the NMDA receptor is considered to be the main culprit of this disorder, its pathogenesis remains unclear. Patients usually develop from influenza-like symptoms to profound neurological impairments in a short time, and multidisciplinary care becomes essential and urgent [4, 5]. Cytokines mentioned previously like interleukin (IL)-6, tumor necrosis factor (TNF)-α have been proposed to play important roles in the pathogenesis of this disease [9,10,11]. We have reported increased inflammatory cytokines in cerebrospinal fluid (CSF) in the acute stage of anti-NMDAR encephalitis [12, 13]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call